Abstract: A recycling bin for classification and compression of renewable resources, comprising a recycling bin housing, and a recycling bin inner container and a pressurizing device provided inside the recycling bin housing, wherein a weighing device is further provided between a bottom of the recycling bin inner container and the recycling bin housing; the pressurizing device comprises a compression beam provided in an upper part of an inner cavity of the recycling bin inner container, and a driving part for driving the compression beam to move; an upper end of the driving part is connected to the compression beam, and a lower end is connected to the bottom of the recycling bin inner container.

Abstract: A bioreactor exhaust system includes an exhaust tube, a shut off valve, and a vessel. The exhaust tube includes a level sensor. The vessel includes a sterilant. The shut off valve is responsive to the sterilant reaching the level sensor.

Abstract: A bioreactor exhaust system includes an exhaust tube, a shut off valve, and a vessel. The exhaust tube includes a level sensor. The vessel includes a sterilant. The shut off valve is responsive to the sterilant reaching the level sensor.

Abstract: A mobile bioreactor service system includes a control interface, a physical interface, and a service system. The control interface connects to one or more valves. The physical interface connects one or more tubes to a bioreactor enabling process fluids to be physically transferred to/from the bioreactor based on a corresponding state of the one or more valves. The service system performs a service on the bioreactor.

Abstract: Systems and methods allow users to query a software-application-based knowledge base to retrieve information. The user creates queries and the specified information is returned through a user interface. In alternative embodiments, the system is able to create follow-up queries independent from or directed by the user. Such embodiments may also provide critical information related to the original query. The knowledge base contains information about the application and is able to provide the appropriate answer to user queries through machine-learning-based tools, such as large language models (LLMs) or other natural language processing (NLP) based techniques.

Abstract: An airlift bioreactor includes a body, a first sparging region, a second sparging region, a first sparger configured to sparge a first gas within the first sparging region, a second sparger configured to sparge a second gas within sparging region, and a controller coupled to the first sparger and the second sparger. The controller is configured to control a first flow rate associated with the first sparger and a second flow rate associated with the second sparger.

Abstract: A sample is introduced from a bioreactor to a chamber included in a manifold. The chamber includes at least a first probe. The at least the first probe is coupled to a controller. One or more measurements are performed on the sample while the sample is located in the chamber for a measurement period. The sample is returned from the chamber to the bioreactor after the one or more measurements of the sample have been performed.

Abstract: An airlift bioreactor includes a body, a first sparging region, a second sparging region, a first sparger configured to sparge a first gas within the first sparging region, a second sparger configured to sparge a second gas within sparging region, and a controller coupled to the first sparger and the second sparger. The controller is configured to control a first flow rate associated with the first sparger and a second flow rate associated with the second sparger.

Abstract: The application relates to a dextran affinity tag and use thereof. The present application provides an affinity tag, which is a segment of dextran binding domain, and can purify a target protein by its affinity with the dextran. The affinity tag of the present application has the advantages of more efficient in preparation and purification, and can be widely used in industrial applications that require protein purification processes.

Abstract: Provided compounds of Formula I and I?, pharmaceutical compositions comprising the compounds, and methods of using the same, in treating, for example, the diseases, disorders, or conditions mediated by the degradation of a protein kinase, such as Hematopoietic progenitor kinase 1 (HPK1).

Abstract: The present disclosure provides compounds of Formula I?, compositions comprising the compound of Formula I?, and methods of using the same, in treating diseases, disorders, or conditions mediated by the inhibition of certain kinases, such as hematopoietic progenitor kinase 1 (HPK1) and/or Fms related receptor tyrosine kinases (FLTs), such as FLT3.

Abstract: The disclosure provides at compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating diseases, disorders of conditions mediated by the signaling of formyl peptide receptor 1 (FPR1).

Abstract: A laundry care or dish care composition can include a poly alpha-1,6-glucan derivative, wherein the poly alpha-1,6-glucan derivative includes: (i) a poly alpha-1,6-glucan backbone of glucose monomer units, wherein greater than or equal to 80% of the glucose monomer units are linked via alpha-1,6 glycosidic linkages, and wherein from about 10% or less of the glucose monomer units are linked via alpha-1,3 glycosidic linkages, 1,2 glycosidic linkages, and/or 1,4 glycosidic linkages; and (ii) at least one organic group linked to the poly alpha-1,6-glucan backbone through a linkage moiety; wherein, the poly alpha-1,6-glucan backbone has a weight average degree of polymerization of at least about 5; wherein, the poly alpha-1,6-glucan derivative has a degree of substitution of linkage moiety of from about 0.20 to about 1.00.

Abstract: A bioreactor includes one or more sensors, a plurality of spargers, a plurality of vertical circulation loops, and a controller coupled to the plurality of spargers and the one or more sensors. The controller is configured to determine that a reading associated with the bioreactor is not at a setpoint, adjust a sparging rate associated with at least one of the plurality of spargers responsive to gas sparging or a liquid additive being introduced to the bioreactor, wherein the sparging rate associated with the at least one of the plurality of spargers is adjusted from a first sparging rate to a second sparging rate, and in response to the reading associated with the bioreactor being consistent and at the setpoint, modify the sparging rate associated with the at least one of the plurality of spargers from the second sparging rate to the first sparging rate.

Abstract: The present disclosure provides a compound configured to release nitric oxide (NO) and inhibit the activity of a phosphodiesterase (PDE) when administered to a subject. The compound may include L1 and L2. L1 may include a functional group that is part or all of a NO releasing agent. L2 may include a functional group that is part or all of a PDE inhibitor. The compound may further include a bond or a biradical that connects L1 and L2. The present disclosure further provides a method of treating or preventing a disease using the compound or a composition including the compound.

Abstract: A laundry care or dish care composition can include a poly alpha-1,6-glucan derivative, wherein the poly alpha-1,6-glucan derivative includes: (i) a poly alpha-1,6-glucan backbone of glucose monomer units, wherein greater than or equal to 40% of the glucose monomer units are linked via alpha-1,6 glycosidic linkages, and wherein from 0% to less than 30% of the glucose monomer units are linked via alpha-1,3 glycosidic linkages, and optionally at least 5% of the backbone glucose monomer units have branches via alpha-1,2 and/or alpha-1,3 glycosidic linkages; and (ii) at least one organic group linked to the poly alpha-1,6-glucan backbone through a linkage moiety; wherein, the poly alpha-1,6-glucan backbone has a weight average degree of polymerization of at least 5; and wherein, the poly alpha-1,6-glucan derivative has a degree of substitution of linkage moiety of from 0.20 to 1.00.

Abstract: A triboelectric nanogenerating device is configured for providing an electric power to an electronic device and the triboelectric nanogenerating device includes at least one scaly triboelectric membrane configured for providing the electric power to the electronic device by frictional electrification. The at least one scaly triboelectric membrane includes a keratin and a polyvinyl alcohol, the at least one scaly triboelectric membrane has a first triboelectric surface, and the first triboelectric surface of the at least one scaly triboelectric membrane includes a plurality of scaly layers. Each of the scaly layers is arranged in order and extends along an orienting direction. A distal end of each of the scaly layers has a plurality of saw-tooth structures.

Abstract: The disclosure provides at compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating diseases, disorders of conditions mediated by the signaling of formyl peptide receptor 1 (FPR1).